SPHERA FUNDS MANAGEMENT LTD
Q3 2026 Form 13-F
TEL AVIV
CIK 0001496201
· CRD 312614
· Exempt reporting adviser
Consolidated report · includes
2 managers
since Q4 2013
$707.5M Reported Value Total
SPHERA FUNDS MANAGEMENT LTD. reports under management (AUM).
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Exempt Reporting Adviser
WWW.SPHERAFUND.COM
Source: Form ADV filed 2026-03-17
Reported value
$707.5M
Quarter over quarter
-10.3%
Holdings
100
Top-10 concentration
33.1%
Filing Structure
Reports holdings for
- Sphera Global Healthcare Management LP · File #028-15865 · since Q4 2013
- Sphera Global Healthcare GP Ltd · File #028-15864 · since Q4 2013
- Sphera Healthcare US Inc. (not a 13F filer in our records) · File #028-21415 · Q3 2021 – Q2 2022
Key People
Named on the latest Form 13-F filing — not necessarily an owner
Oshrat Levi
Chief Financial Officer
Filing Navigation
13F Metrics
Loading 13F Metrics
Q3 2026 13F record
Q3 2026 13F filing summary
| Period of report | September 30, 2026 |
|---|---|
| Filed | November 16, 2026 |
| Form | 13F-HR |
| Reported value | $707.5M |
| Positions | 100 |
| Change in reported value | -7.7% |
| New positions | 22 |
| Exited positions | 19 |
| Position turnover | 34.5% |
| Top-10 concentration | 33.1% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2026 13F
Filed Nov 16, 2026
|
100 | $707.5M |
|
Q2 2026 13F
Filed Aug 14, 2026
|
97 | $766.5M |
|
Q1 2026 13F
Filed May 15, 2026
|
92 | $629.7M |
|
Q4 2025 13F
Filed Feb 17, 2026
|
94 | $517.3M |
|
Q3 2025 13F
Filed Nov 14, 2025
|
101 | $474.1M |
|
Q2 2025 13F
Filed Aug 14, 2025
|
101 | $426.1M |
|
Q1 2025 13F
Filed May 15, 2025
|
112 | $434.3M |
|
Q4 2024 13F
Filed Feb 14, 2025
|
103 | $553.1M |
|
Q3 2024 13F
Filed Nov 14, 2024
|
108 | $628.4M |
|
Q2 2024 13F
Filed Aug 14, 2024
|
110 | $733.2M |
|
Q1 2024 13F
Filed May 15, 2024
|
93 | $711.7M |
|
Q4 2023 13F
Filed Feb 14, 2024
|
89 | $621.3M |
|
Q3 2023 13F
Filed Nov 14, 2023
|
75 | $549.0M |
|
Q2 2023 13F
Filed Aug 14, 2023
|
76 | $640.4M |
|
Q1 2023 13F
Filed May 15, 2023
|
75 | $598.4M |
|
Q4 2022 13F
Filed Feb 14, 2023
|
58 | $465.9M |
|
Q3 2022 13F
Filed Nov 14, 2022
|
65 | $720.5M |
|
Q2 2022 13F
Filed Aug 15, 2022
|
50 | $934.9M |
|
Q1 2022 13F
Filed May 16, 2022
|
59 | $707.6M |
|
Q4 2021 13F
Filed Feb 14, 2022
|
85 | $909.6M |
32 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q3 2026
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | MLYS MINERALYS THERAPEUTICS INC | $33.2M | 4.7% |
| 2 | TEVA TEVA PHARMACEUTICAL INDS LTD | $32.5M | 4.6% |
| 3 | ALNY ALNYLAM PHARMACEUTICALS INC | $29.8M | 4.21% |
| 4 | CYTK CYTOKINETICS INC | $23.9M | 3.37% |
| 5 | SOXX ISHARES TR | $21.0M | 2.97% |
| 6 | BBIO BRIDGEBIO PHARMA INC | $20.5M | 2.9% |
| 7 | TSEM TOWER SEMICONDUCTOR LTD | $19.3M | 2.72% |
| 8 | SNDX SYNDAX PHARMACEUTICALS INC | $18.9M | 2.68% |
| 9 | BMRN BIOMARIN PHARMACEUTICAL INC | $17.6M | 2.49% |
| 10 | BIIB BIOGEN INC | $17.1M | 2.42% |
| 11 | COGT COGENT BIOSCIENCES INC | $16.1M | 2.27% |
| 12 | NVMI NOVA LTD | $15.0M | 2.13% |
| 13 | MDGL MADRIGAL PHARMACEUTICALS INC | $13.0M | 1.84% |
| 14 | XBI P SPDR SERIES TRUST | $11.8M | 1.67% |
| 15 | META META PLATFORMS INC | $11.7M | 1.66% |
| 16 | IMTX IMMATICS N.V | $11.5M | 1.62% |
| 17 | SNY SANOFI SA | $11.1M | 1.57% |
| 18 | AZN ASTRAZENECA PLC | $11.1M | 1.56% |
| 19 | ARKG P ARK ETF TR | $10.8M | 1.53% |
| 20 | MAZE MAZE THERAPEUTICS INC | $10.0M | 1.41% |
Values as reported on the Q3 2026 Form 13F. Every position is in the holdings table below.